IceCure Medical (ICCM) Cost of Revenue (2025 - 2026)

IceCure Medical (ICCM) reported Cost of Revenue of $616000.0 for Q1 2026, up 21.5% year-over-year from $507000.0 in Q1 2025, and up 21.5% on a QoQ basis from $507000.0 in Q1 2025.

IceCure Medical (ICCM) has 2 years of Cost of Revenue data on file, last reported at $616000.0 in Q1 2026.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cost of Rev (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn 4.89 Bn
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn 2.21 Bn
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn 3.26 Bn
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn 1.59 Bn
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn 362.60 Mn
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn 2.51 Bn
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn 441.60 Mn
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn 481.00 Mn
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn 891.20 Mn
10 IceCure Medical 12.09 -8.11 Mn 295,000.00 616,000.00

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 616,000.00
Mar 31, 2026 616,000.00
Mar 31, 2025 507,000.00
Mar 31, 2025 507,000.00